文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

萝卜硫素依赖的NRF2活性上调减轻小鼠失血性休克/复苏后的全身炎症反应和肺损伤

Sulforaphane-Dependent Up-Regulation of NRF2 Activity Alleviates Both Systemic Inflammatory Response and Lung Injury After Hemorrhagic Shock/Resuscitation in Mice.
PubMed 文献 · Shock · 2022-01-01
一句话结论小鼠失血性休克/复苏模型中,腹腔注射萝卜硫素增强肺Nrf2活性并抑制肺泡巨噬细胞及全身促炎介质,减轻肺损伤。

该研究在雄性C57/BL6野生型及ARE-荧光素酶转基因小鼠(每组n=6)中建立压力控制性失血性休克/复苏模型(平均动脉压35-45 mmHg持续90分钟),复苏经回输抽出的血液和0.9%盐水完成,萝卜硫素或0.9%盐水(溶剂)经腹腔给药,于复苏后6、24或72小时处死。结果显示失血性休克/复苏本身伴随肺Nrf2激活,萝卜硫素进一步增强肺Nrf2活性及肺泡巨噬细胞Nrf2核内聚集,降低肺损伤,并下调肺泡巨噬细胞生成及全身促炎介质,但对IL-10无此作用。提示复苏后给予Nrf2激活剂可能成为创新治疗策略。

要点

  • 在雄性C57/BL6小鼠失血性休克/复苏模型(MAP 35-45 mmHg×90分钟)中,腹腔注射萝卜硫素增强肺Nrf2活性并促进肺泡巨噬细胞Nrf2核内聚集。
  • 萝卜硫素降低失血性休克/复苏后肺损伤(急性肺损伤评分及湿/干比评估),并下调肺泡巨噬细胞生成及全身促炎介质。
  • 萝卜硫素对IL-10无下调作用,提示其抗炎效应可能选择性针对促炎介质。
  • 失血性休克/复苏本身即可激活肺Nrf2,萝卜硫素是在此基础上的进一步增强。
  • 上述结果为小鼠模型证据,萝卜硫素的人体剂量、给药途径与疗程均未在原文中确立。

适用人群与场景

  • 雄性C57/BL6野生型及ARE-荧光素酶转基因小鼠(每组n=6),接受压力控制性失血性休克/复苏(平均动脉压35-45 mmHg持续90分钟)或假手术,或不做干预直接处死(对照组)。
  • 原文未提及人类适用人群、排除人群及具体急诊/ICU场景。

诊断标准与关键阈值

  • 失血性休克模型标准:压力控制性失血使平均动脉压维持在35-45 mmHg,持续90分钟。
  • 原文未提及临床诊断标准、评分界值或启动/停止治疗阈值。

处置流程与药物剂量

  • 液体复苏方式:回输抽出的血液和0.9%盐水(原文未给出具体容量、速度或目标值)。
  • 萝卜硫素或0.9%盐水(溶剂)经腹腔注射给药(原文未给出剂量、浓度、频次或疗程)。
  • 于复苏后6、24或72小时处死小鼠进行检测(原文未提及人体给药时机)。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:隔离小鼠失血性休克/复苏模型实验;样本量:野生型及ARE-荧光素酶转基因小鼠各每组n=6;未提及多中心。
  • 失血性休克/复苏与肺Nrf2激活相关;萝卜硫素增强肺Nrf2活性及肺泡巨噬细胞Nrf2激活,同时减轻肺损伤。
  • 萝卜硫素下调肺泡巨噬细胞生成及全身促炎介质,但对IL-10无此下调作用。
  • 肺损伤通过急性肺损伤评分和湿/干比评估;原文未给出具体评分值、湿/干比数值、细胞因子浓度及P值。

证据类型、等级与局限

  • 证据类型:动物实验研究(小鼠模型);原文未给出证据等级或推荐强度。
  • 局限:仅为小鼠模型,样本量小(每组n=6),单中心/单实验室,未提供人体数据;萝卜硫素剂量、给药方案及临床转化价值未在原文中确立。

对床旁实践的改变

  • 该内容提示复苏后给予Nrf2激活剂(如萝卜硫素)可能通过增强肺Nrf2活性、抑制肺泡巨噬细胞及全身促炎介质来减轻失血性休克/复苏后肺损伤,但仅为小鼠模型证据。
  • 原文未提供人体剂量、给药途径、疗程或适用/不适用人群,不能直接改变急诊/ICU床旁补液、输血或抗炎治疗的具体做法。
  • 常见陷阱:不能将小鼠腹腔注射的萝卜硫素方案外推为临床推荐;不能将模型中的平均动脉压35-45 mmHg当作临床复苏目标。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Hemorrhagic shock/resuscitation (HS/R) is closely associated with overwhelming oxidative stress and systemic inflammation. As an effective activator of the nuclear factor-erythroid factor 2 related factor 2 (Nrf2) pathway, sulforaphane (SFN) exerts antioxidant and anti-inflammatory effects. We explored SFN's effects on alveolar macrophages (AMs), systemic inflammation, and pulmonary damage in an isolated murine HS/R model. Male C57/BL6 wild type and transgenic antioxidant response element (ARE)-luciferase (luc) mice (both n = 6 per group) were exposed to either pressure-controlled HS/R (mean arterial pressure 35-45 mm Hg for 90 min) or sham procedure (surgery without HS/R) or were sacrificed without intervention (control group). Fluid resuscitation was performed via the reinfusion of withdrawn blood and 0.9% saline. Sulforaphane or 0.9% saline (vehicle) was administrated intraperitoneally. Mice were sacrificed 6, 24, or 72 h after resuscitation. Bioluminescence imaging of ARE-luc mice was conducted to measure pulmonary Nrf2 activity. Plasma was collected to determine systemic cytokine levels. Alveolar macrophages were isolated before measuring cytokines in the supernatant and performing immunofluorescence staining, as well as Western blot for intracellular Nrf2. Histological damage was assessed via the acute lung injury score and wet/dry ratio.Hemorrhagic shock/resuscitation was associated with pulmonary Nrf2 activation. Sulforaphane enhanced pulmonary Nrf2 activity and the Nrf2 activation of AM, while it decreased lung damage. Sulforaphane exerted down-regulatory effects on AM-generated and systemic pro-inflammatory mediators, while it did not have such effects on IL-10.In conclusion, SFN beneficially enhances pulmonary Nrf2 activity and promotes Nrf2 accumulation in AMs' nuclei. This may exert not only local protective effects but also systemic effects via the down-regulation of pro-inflammatory cytokines. The administration of Nrf2 activator post-HS/R may represent an innovative treatment strategy.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Liang W, Greven J, Fragoulis A, et al. Sulforaphane-Dependent Up-Regulation of NRF2 Activity Alleviates Both Systemic Inflammatory Response and Lung Injury After Hemorrhagic Shock/Resuscitation in Mice. Shock. 2022. PMID: 34559743. doi:10.1097/SHK.0000000000001859

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。